International Journal of Pharmaceutical Compounding

A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

LEARN MORE

FDAMA Proposed List of Agents Not to be Compounded due to Withdrawal for Safety/Efficacy Concerns

Author(s): Allen Loyd V Jr

Issue: Jan/Feb 1999 - Dental Compounding
View All Articles in Issue

Page(s): 25-29

FDAMA Proposed List of Agents Not to be Compounded due to Withdrawal for Safety/Efficacy Concerns Page 1

FDAMA Proposed List of Agents Not to be Compounded due to Withdrawal for Safety/Efficacy Concerns Page 2

FDAMA Proposed List of Agents Not to be Compounded due to Withdrawal for Safety/Efficacy Concerns Page 3

FDAMA Proposed List of Agents Not to be Compounded due to Withdrawal for Safety/Efficacy Concerns Page 4

FDAMA Proposed List of Agents Not to be Compounded due to Withdrawal for Safety/Efficacy Concerns Page 5

Download in electronic PDF format for $65

Abstract: The US Food and Drug Administration has proposed that drug products listed in the table provided here be included on the list of drug products withdrawn or removed from the market because they have been found to be unsafe or ineffective. Therefore, compounding a drug product on this list would not be covered by the exemption provided in Section 503A(a) of the Federal Food and Drug Administration Modernization Act of 1997. The list originally appeared in the October 8, 1998, Federal Register (63[195]:54083-54087). Listings are mostly alphabetical. Reasons for withdrawal and withdrawal dates are also provided.

Related Keywords: Safety, Efficacy

Related Categories: LEGAL

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
FDAMA Proposed List of Agents Not to be Compounded due to Withdrawal for Safety/Efficacy Concerns Allen Loyd V Jr	Jan/Feb 1999 Pg. 25-29
Safety Standards in Pharmaceutical Compounding, Part 3: Fire Safety Allen W Chris, Greeson Nicole MH, Mixon William	Nov/Dec 2020 Pg. 451-458
Efficacy and Tolerability of Compounded Bioidentical Hormone Replacement Therapy Vigesaa Kristy A, Downhour Nathan P, Chui Michelle A, Cappellini Linda, Musil John D, McCallian Dennis J	Jul/Aug 2004 Pg. 313-319
Safety and Efficacy Studies, Pharmacy Education, and the NASEM Report on Compounded Topical Pain Creams Allen Loyd V Jr	Sep/Oct 2020 Pg. 356
Wetting and/or Solubilizing Agents, Featured Excipient: Allen Loyd V Jr	Jul/Aug 2001 Pg. 310-312
Safety Standards in Pharmaceutical Compounding, Part 1: The Occupational Safety and Health Administration Greeson Nicole MH, Mixon William, Allan W Chris	Jul/Aug 2020 Pg. 270-276
Safety Standards in Pharmaceutical Compounding, Part 2: A Closer Look at Agency Information, Oversight, and Assistance Greeson Nicole MH, Mixon William, Allan W Chris	Sep/Oct 2020 Pg. 371-379
Basics of Compounding: The Revised "Not to Compound List" Allen Loyd V Jr	Jan/Feb 2015 Pg. 57-58
Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi	Jul/Aug 2015 Pg. 295-300
Complying with Occupational Safety and Health Administration Regulations: A Guide for Compounding Pharmacists Mixon Bill, Nain John	May/Jun 2013 Pg. 182-190
Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations Ashe Krystina, Baskett Dustin	Sep/Oct 2018 Pg. 387-398
How to Develop and Maintain a Hazardous Drug List Dillon L Rad	May/Jun 2019 Pg. 182-186
Quality Control: (Material) Safety Data Sheets Allen Loyd V Jr	Mar/Apr 2017 Pg. 118-124
Safety for Employees in the Compounding Work Area Allen Loyd V Jr	Jan/Feb 2002 Pg. 60-61
Efficacy and Clinical Value of Commonly Compounded Hormone Replacement Therapy: A Literature Review Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi	Jan/Feb 2015 Pg. 6-12
Quality Control Analytical Methods: A Growing Codependency: Compounding Pharmacy and Safety Prince Bryan, Lundeval Jeremy	Nov/Dec 2013 Pg. 485-489
Determining Whether a Substance is Legal to Compound with Under Section 503A of the FDCA Cabaleiro Joe	Sep/Oct 2021 Pg. 358-362
The "Lists": What Do They Mean? Voliva John	Nov/Dec 2016 Pg. 477-479
Auditing Safety of Compounding and Reconstituting of Intravenous Medicines on Hospital Wards in Finland Suvikas-Peltonen Eeva, Palmgren Joni, Häggman Verner, Celikkayalar Ercan, Manninen Raija, Airaksinen Marja	Nov/Dec 2017 Pg. 518-529
Efficacy of an Automated Robotic Cleaning Device for Compounding Pharmacies Polonini Hudson, Dijkers Eli CF, Ferreira Anderson O, da Silva Sharlene L, Araújo Paulo Victor C, Koulouridas Savvas	Sep/Oct 2020 Pg. 426-433